5 October 2024

Howe Street Reporter Title

Tag: compass pathways

  • Today’s Idea: Filament Health’s (FH.NE) psychedelics play

    Today’s Idea: Filament Health’s (FH.NE) psychedelics play

    Our Psychedelic Trip Isn’t Over I don’t know the first thing about psychedelics. Rather, that’s what I would have been saying back in 2020 when the psychedelics sector was experiencing an unprecedented breakout period. Maybe it was because of mainstream media or perhaps it was my nagging parents, but I have always feared psychedelics. Back…

  • The top 10 most cashed up psychedelics companies right now

    The top 10 most cashed up psychedelics companies right now

    “In business, cash is oxygen” – Gary Vaynerchuk Psychedelics is a cash-intensive business. Earlier in the week, I wrote about how clinical trials alone cost companies tens, sometimes hundreds of millions of dollars. And that’s only part of the picture. According to Tufts Center for the Study of Drug Development, bringing a new FDA-approved drug…

  • Compass Pathways (CMPS.Q) is rubbing investors the wrong way, again

    Compass Pathways (CMPS.Q) is rubbing investors the wrong way, again

    Cut the kumbaya shit Throwing the words profit and psychedelic drugs into a sentence would have lead to awkward and confused looks 5 years ago. But we have come a long way, and in that process, questions have arisen like: how do money and psychedelics mix? Psychedelic medicine advocates who have never been around the…